Pioglitazone for Lung Cancer Chemoprevention

Clinical trial NCT00780234 · COMPLETED

Trial details

NCT number: NCT00780234
Sponsor: VA Office of Research and Development
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lung Cancer Endobronchial Dysplasia

Start date: 2009-08-01
Primary completion: 2016-06-01
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.